ALR Technologies SG Ltd. Stock Analysis ALRTF
ALR Technologies SG Ltd. is a data management company, which engages in providing healthcare management solutions. The company has developed a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA-compliant Diabetes Solution product that collects data from blood glucose meters (BGM) and continuous glucose monitoring device (CGM); a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. From this technology portfolio, the Company has developed the Diabetes Solution product for human health, and the GluCurve product for animal health. The firm is focused on the enhancement of adherence to disease and healthcare management programs through artificial intelligence, machine learning, patient monitoring, and improved communications. Its primary business markets are healthcare providers, the providers of health insurance, and the providers of disease and care management services, including the home care industry.
Read More ALR Technologies SG Ltd (ALRTF) Chart
Key Statistics of ALR Technologies SG Ltd (ALRTF)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.01Volume
37.50KP/E Ratio (TTM)
-52 Week Range
Market Cap
10.18MAvg. Volume
20.09KDividend Yield
-Financial Metrics & Statements of ALR Technologies SG Ltd (ALRTF)
FAQ's for ALR Technologies SG Ltd (ALRTF)
- According to Musaffa’s Shariah screening methodology, ALR Technologies SG Ltd (ALRTF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.